26 May 2022

Professor Sheila Glennis Haworth Memorial Symposium on Paediatric PH

Watch the replay

Agenda

  • Wendy Chung // Genetics of pulmonary arterial hypertension.  What we can learn by studying  children with and without congenital heart disease
  • Mark Grady // Therapeutic options in advanced PVD: Potts shunt versus lung transplantation
  • Bernard Thebaud // Stem cells and Regenerative Medicine for Neonatal Lung Disease: implications for COPD
  • Erika B. Rosenzweig // Assessment of operability in patients with congenital heart disease and PAH: Fallacies and pitfalls 
  • Gabriela de Carvalho Nunes // The impact of chronic pulmonary hypertension on ventricular function in extremely premature infants
  • Ronald Day // Improving guidance for the correctability of congenital cardiovascular shunts with increased pulmonary vascular resistance

Poll results

Start of webinar poll

1. Talk 1: BMPR2 mutations can be found in patients with pulmonary hypertension with our without congenital heart disease

True - 100%

False - 0%

 

2. Talk 2: Long term outcomes for children undergoing a Potts shunt are comparable to lung transplantation?

Agree - 57%

Disagree - 43%

 

3. Talk 3: Is there such thing as a “vascular phenotype” in BPD?

Yes - 86%

No - 14%

 

4. Talk 4: Once you identify as congenital systemic to pulmonary shunt in a patient with pulmonary hypertension, you should immediately close

Yes - 21%

No - 79%

 

5. Talk 5: Do you think that all extreme premature infants with any degree of bronchopulmonary dysplasia should be screened for pulmonary hypertension at term?

Yes - 93%

No - 7%

 

6. Talk 6: Acute vasodilator testing with oxygen and inhaled nitric oxide should be used when using a preoperative hemodynamic evaluation to determine the correctability of a cardiovascular shunt.

Agree - 93%

Disagree - 7%

 

End of webinar poll

1. Talk 1: BMPR2 mutations can be found in patients with pulmonary hypertension with our without congenital heart disease

True - 100%

False - 0%

 

2. Talk 2: Long term outcomes for children undergoing a Potts shunt are comparable to lung transplantation?

Agree - 43%

Disagree - 57%

 

3. Talk 3: Is there such thing as a “vascular phenotype” in BPD?

Yes - 86%

No - 14%

 

4. Talk 4: Once you identify as congenital systemic to pulmonary shunt in a patient with pulmonary hypertension, you should immediately close

Yes - 21%

No - 79%

 

5. Talk 5: Do you think that all extreme premature infants with any degree of bronchopulmonary dysplasia should be screened for pulmonary hypertension at term?

Yes - 93%

No - 7%

 

6. Talk 6: Acute vasodilator testing with oxygen and inhaled nitric oxide should be used when using a preoperative hemodynamic evaluation to determine the correctability of a cardiovascular shunt.

Agree - 93%

Disagree - 7%


Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg